2-44942680-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_005413.4(SIX3):​c.576C>T​(p.Arg192Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0212 in 1,601,098 control chromosomes in the GnomAD database, including 455 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.028 ( 84 hom., cov: 32)
Exomes 𝑓: 0.021 ( 371 hom. )

Consequence

SIX3
NM_005413.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.691

Publications

6 publications found
Variant links:
Genes affected
SIX3 (HGNC:10889): (SIX homeobox 3) This gene encodes a member of the sine oculis homeobox transcription factor family. The encoded protein plays a role in eye development. Mutations in this gene have been associated with holoprosencephaly type 2. [provided by RefSeq, Oct 2009]
SIX3-AS1 (HGNC:40532): (SIX3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 2-44942680-C-T is Benign according to our data. Variant chr2-44942680-C-T is described in ClinVar as Benign. ClinVar VariationId is 65500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.691 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0275 (4188/152284) while in subpopulation AFR AF = 0.0491 (2041/41550). AF 95% confidence interval is 0.0473. There are 84 homozygotes in GnomAd4. There are 2008 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 84 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIX3NM_005413.4 linkc.576C>T p.Arg192Arg synonymous_variant Exon 1 of 2 ENST00000260653.5 NP_005404.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIX3ENST00000260653.5 linkc.576C>T p.Arg192Arg synonymous_variant Exon 1 of 2 1 NM_005413.4 ENSP00000260653.3
ENSG00000225156ENST00000760330.1 linkn.135+8304C>T intron_variant Intron 1 of 1
SIX3-AS1ENST00000760560.1 linkn.389-1847G>A intron_variant Intron 1 of 1
SIX3-AS1ENST00000760561.1 linkn.365+1707G>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
4160
AN:
152166
Hom.:
78
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0486
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0172
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.00290
Gnomad SAS
AF:
0.0241
Gnomad FIN
AF:
0.0120
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0211
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0200
AC:
4740
AN:
236806
AF XY:
0.0206
show subpopulations
Gnomad AFR exome
AF:
0.0486
Gnomad AMR exome
AF:
0.0135
Gnomad ASJ exome
AF:
0.0312
Gnomad EAS exome
AF:
0.00124
Gnomad FIN exome
AF:
0.0122
Gnomad NFE exome
AF:
0.0201
Gnomad OTH exome
AF:
0.0248
GnomAD4 exome
AF:
0.0206
AC:
29832
AN:
1448814
Hom.:
371
Cov.:
33
AF XY:
0.0208
AC XY:
14976
AN XY:
721110
show subpopulations
African (AFR)
AF:
0.0519
AC:
1738
AN:
33458
American (AMR)
AF:
0.0145
AC:
646
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
775
AN:
26110
East Asian (EAS)
AF:
0.00166
AC:
66
AN:
39656
South Asian (SAS)
AF:
0.0233
AC:
2010
AN:
86154
European-Finnish (FIN)
AF:
0.0123
AC:
507
AN:
41194
Middle Eastern (MID)
AF:
0.0220
AC:
127
AN:
5764
European-Non Finnish (NFE)
AF:
0.0203
AC:
22613
AN:
1111576
Other (OTH)
AF:
0.0224
AC:
1350
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1890
3779
5669
7558
9448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0275
AC:
4188
AN:
152284
Hom.:
84
Cov.:
32
AF XY:
0.0270
AC XY:
2008
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0491
AC:
2041
AN:
41550
American (AMR)
AF:
0.0172
AC:
263
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3470
East Asian (EAS)
AF:
0.00290
AC:
15
AN:
5168
South Asian (SAS)
AF:
0.0241
AC:
116
AN:
4816
European-Finnish (FIN)
AF:
0.0120
AC:
127
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0211
AC:
1438
AN:
68032
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
210
421
631
842
1052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0129
Hom.:
4
Bravo
AF:
0.0278
Asia WGS
AF:
0.0160
AC:
59
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32022405) -

Oct 13, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SIX3: BP4, BP7, BS1, BS2 -

Oct 25, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Holoprosencephaly 2 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 29, 2013
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation

- -

Schizencephaly;C1834877:Holoprosencephaly 2 Benign:1
Oct 05, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
13
DANN
Benign
0.91
PhyloP100
0.69
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182881; hg19: chr2-45169819; COSMIC: COSV53226782; COSMIC: COSV53226782; API